Regenerative medicine focus of major new Monash collaboration

Regenerative medicine focus of major new Monash collaboration

Monash University’s internationally recognised Australian Regenerative Medicine Institute (ARMI) will team up with CSIRO and other major players in the Australian regenerative medicine sector to establish a hub of the renowned Canadian-based Centre for Commercialisation of Regenerative Medicine (CCRM).

CCRM Australia will mobilise and apply business and scientific expertise to translate cell and gene therapies and regenerative medicine technologies into commercial products and therapies.

The new initiative, to be based in Melbourne and announced today by Victorian Minister for Small Business, Innovation and Trade the Hon. Philip Dalidakis MP at the opening of Biotech Invest in Melbourne, has received investment from state and federal government.

Director of ARMI at Monash Professor Peter Currie welcomed the government support and explained how this new national initiative will create a powerhouse for the commercialisation of regenerative medicine, ultimately improving health outcomes for thousands of people across Australia and globally:

“At ARMI we are making huge strides in finding ways to tap into the human body’s remarkable potential to heal and regenerate from injury or disease. Combining our research capabilities using the renowned Centre for Commercialisation of Regenerative Medicine in Canada will create an extraordinary and powerful research and commercialisation capability that will really help improve people’s lives,” Professor Currie said.

CCRM Australia will focus on technology development, company creation and speeding up the process of commercialising regenerative medicine technologies and cell-based therapies making them available to Australians, and the world, sooner.

Whilst Australia’s Melbourne based CCRM will be a separate entity to the Toronto centre, the two will work in synergy. Future CCRM hubs are planned for other regions advancing world-leading discoveries in regenerative medicine to create a truly international network of innovation and translation in the field.